Glycopeptide antibiotics

Nov 11, 2019

TenNor Therapeutics Reported Phase II Top-Line Results for TNP-2092

Jun 20, 2019

ANI Pharmaceuticals Announces Approval of Vancomycin Hydrochloride for Oral Solution USP, 250mg/5ml

Apr 03, 2019

Correvio Announces Xydalba(TM) (Dalbavancin Hydrochloride) Abstracts at ECCMID 2019

Feb 27, 2019

Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI

Nov 26, 2018

MicuRx Enrolls First Patient in a Phase 2 Clinical Trial in U.S. for Novel Antibiotic, Contezolid Acefosamil

Apr 12, 2018

Cardiome Announces Fifteen Xydalba(TM) and Zevtera® Abstracts at ECCMID 2018

Mar 22, 2018

Health Canada Accepts Cardiome's Xydalba New Drug Submission and Grants Priority Review

Dec 11, 2017

Cardiome Announces Xydalba(TM) Treatment And Patient Experience Presentations At The 2017 National Opat Conference

Oct 30, 2017

Cardiome Announces Commercial Launch of Xydalba(TM) in Three New European Geographies

Jun 21, 2017

Cardiome Announces Licensing Agreement for XYDALBA(TM) (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel